Canagliflozin Alleviates Experimental Antineutrophil Cytoplasmic Antibody–Associated Vasculitis through Suppression of Pathogenic T-Cell Responses

Canagliflozin Alleviates Experimental Antineutrophil Cytoplasmic Antibody–Associated Vasculitis through Suppression of Pathogenic T-Cell Responses | ReachRx